Hyperbaric oxygen in radiation therapy

Area of Science:

• Radiation oncology
• Medical physics
• Cancer research

Background:

• Oxygen's established role in enhancing the effects of low-linear energy transfer (LET) radiation across various biological systems.
• Previous studies suggest potential benefits of hyperbaric oxygen (HBO) in treating certain cancers, notably head and neck tumors.

Purpose of the Study:

• To critically evaluate the unequivocal evidence for hyperbaric oxygen's superiority compared to conventional radiotherapy.
• To determine the potential survival gains from HBO, especially in earlier stages of disease and specific tumor sites.

Main Methods:

• Review and analysis of existing studies on hyperbaric oxygen and radiotherapy.
• Focus on well-controlled trials, particularly those involving head and neck cancers.
• Consideration of outcomes in different disease stages.

Main Results:

• While some studies show impressive results, particularly for head and neck tumors, HBO has not been unequivocally proven superior to conventional radiotherapy.
• Any survival advantage gained from HBO is likely limited, especially in advanced disease stages.

Conclusions:

• Further well-controlled clinical trials are essential to establish the definitive role of hyperbaric oxygen in cancer treatment.
• Head and neck tumors represent a promising area for future research, with even a modest survival improvement having significant impact.
• Continued investigation into HBO, other oxygen modalities, particle therapy, and radiosensitizing drugs is warranted to overcome the oxygen effect in human tumors.